Autoreactive T Cells Recognize MBP Peptides Naturally Presented by EBV-Infected B Cells and Multiple Sclerosis Brain Tissue
Epstein-Barr virus (EBV) is involved in causing and probably also perpetuating multiple sclerosis (MS). Among several mechanisms, how EBV may contribute, are transcriptome alterations including changes of antigen processing and preferential presentation of both viral and self-antigens. Here, we found that EBV reprograms the transcriptome and immunopeptidome presented on the MS-associated HLA-DR15 molecules of infected B cells. Identical myelin basic protein (MBP) peptides were found to be presented on both EBV-infected B cells and MS brain tissue but not primary B cells and thymic tissue. Peripheral memory and cerebrospinal fluid (CSF)-derived CD4+ T cells of HLA-DR15+ MS patients responded to MBP peptides, MBP(78-90) and/or MBP(83-90), and T cell clones raised with these peptides recognized all MBP peptides ending at amino acid MBP90 in MS brain tissues. Our study provides a new mechanistic link how the environmental and genetic risk factors, EBV infection and HLA-DR15 haplotype, may contribute jointly to MS.